Please assess the completion status of the following clinical trial:

Trial Title: Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Males and non-child bearing potential females between 18 and 45 years of age, inclusive.~* BMI between 19 and 32 kg/m2, inclusive.~Exclusion Criteria:~* Condition or history which may present a safety concern to the subject or interfere with outcome variables.~* History of or current drug or alcohol abuse, hepatitis, AIDS, or drug allergy.~* Use of prescription, over-the-counter, or herbal medication, or vitamin supplements within 14 days or antibiotics within 30 days.~* Use of tobacco products or daily exposue to second hand smoke.~* Blood pressure higher than 140/90 mmHg or lower than 100/50 mmHg: heart rate outside 40 to 90 beats/minute.~* History of serious mental disorder.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).